CHF Solutions raises $26 million for product launch:
This article was originally published in Clinica
Private company CHF Solutions, which is developing a mechanical pump/filter to remove excess fluid from patients, has closed a $26m series D financing. The Brooklyn Park, Minnesota-based company plans to use the funds to set up a sales and marketing infrastructure for direct US distribution, to build inventory, for international launch and US clinical trials of its product, the System 100 fluid removal system. In congestive heart failure alone, some five million people in the US suffer from fluid overload, which costs more than $23bn annually, the company says.
You may also be interested in...
Switzerland’s SIX exchange-listed drug development company, Basilea, is moving two new oncology candidates along its R&D pipeline, supported by strong revenues from two partnered anti-infective products.
Recommendations from the Alliance for Regenerative Medicine aim to improve cross-border healthcare to ensure patients can access advanced therapies.
At the OurCrowd Global Investor Summit in Jerusalem, Israel, on 13 February, Medtech Insight met wound care device company Nanomedic to find out more about its unique electro-spinning technology.